Comparison of Clinical Effects of Azathioprine and Rituximab NMO-SD Patients
Status:
Completed
Trial end date:
2016-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare annual relapse rate, expanded disability status
scale, and side effects of azathioprine and rituximab in patients with neuromyelitis optica
spectrum disorder during a one year follow up through a randomized clinical trial.